Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
IMAX | IMAX | Apr 26, 2024 | 17.15 | -1.78 |
Immatics | IMTX | Apr 26, 2024 | 10.01 | +2.35 |
Immersion | IMMR | Apr 26, 2024 | 7.19 | +0.84 |
Immix Biopharma | IMMX | Apr 26, 2024 | 2.13 | +1.43 |
ImmuCell | ICCC | Apr 26, 2024 | 5.14 | +0.78 |
Immuneering A | IMRX | Apr 26, 2024 | 1.47 | +2.80 |
Immunic | IMUX | Apr 26, 2024 | 1.22 | -3.17 |
ImmunityBio | IBRX | Apr 26, 2024 | 7.35 | +43.84 |
Immunocore ADR | IMCR | Apr 26, 2024 | 58.46 | +0.79 |
Immunome | IMNM | Apr 26, 2024 | 13.73 | -3.72 |
ImmunoPrecise Antibodies | IPA | Apr 26, 2024 | 1.32 | +10.55 |
Immunovant | IMVT | Apr 26, 2024 | 27.17 | -2.09 |
Immutep ADR | IMMP | Apr 26, 2024 | 2.65 | +1.92 |
Imperial Oil | IMO | Apr 26, 2024 | 70.70 | -0.80 |
Imperial Petroleum | IMPP | Apr 26, 2024 | 3.57 | +3.18 |
Imperial Petroleum A Pref | IMPPP | Apr 26, 2024 | 23.90 | +0.04 |
Impinj | PI | Apr 26, 2024 | 150.91 | -2.98 |
Imunon | IMNN | Apr 26, 2024 | 1.44 | 0.00 |
IN8bio | INAB | Apr 26, 2024 | 1.04 | 0.00 |
Inari Medical | NARI | Apr 26, 2024 | 38.42 | +0.92 |
Incannex Healthcare ADR | IXHL | Apr 26, 2024 | 2.22 | -3.48 |
Inception Growth Acquisition | IGTA | Apr 26, 2024 | 11.02 | -0.12 |
Inception Growth Acquisition Unit | IGTAU | Apr 26, 2024 | 12.07 | 0.00 |
Income Opportunity Realty Investors | IOR | Apr 26, 2024 | 16.78 | +1.89 |
Incyte | INCY | Apr 26, 2024 | 51.68 | +0.98 |
Indaptus Therapeutics | INDP | Apr 26, 2024 | 2.11 | -3.21 |
Independence Contract Drilling | ICD | Apr 26, 2024 | 1.86 | -4.12 |
Independence Realty Trust | IRT | Apr 26, 2024 | 15.86 | +1.28 |
Independent Bank | INDB | Apr 26, 2024 | 52.73 | +0.73 |
Independent Bank | IBCP | Apr 26, 2024 | 24.99 | -0.72 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.